Richard H. Shoop, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 2587 Merced St, San Leandro, CA 94577 Phone: 615-778-4066 Fax: 615-778-9114 |
News Archive
The U.S. Food and Drug Administration today approved Berinert, the first treatment for acute abdominal attacks and facial swelling associated with a rare and potentially life-threatening genetic disease called hereditary angioedema (HAE).
A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
A computer vision technology developed by University of Cambridge engineers has now been developed into a free mobile phone app for regular monitoring of glucose levels in people with diabetes.
The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
Federal agencies should assess the safety of genetically altered foods - whether produced by genetic engineering or by other techniques, such as conventional breeding for desirable traits - on a case-by-case basis to determine whether unintended changes in their composition could adversely affect human health, says a new report from the National Academies' National Research Council and Institute of Medicine.
› Verified 6 days ago